Magellan Health, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
9/10
|
7.95 | 57.21 | -86.1% | 25.32 | -68.61% |
| P/S |
|
0.5 | 33.44 | -98.5% |
|
|
| P/BV |
|
1.3 | 4.65 | -72.03% |
|
|
| P/FCF |
|
6.4 | 39.66 | -83.86% |
|
|
| Ev/Ebitda |
|
16.66 | -17.68 | -194.25% |
|
|
| Ev/S |
|
0.4128 | 22.52 | -98.17% |
|
|
| Ev/FCF |
|
5.12 | 47.58 | -89.25% |
|
|
| E/P |
|
0.1193 | 0.0172 | 591.7% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
1/10
|
2.49 | -14.58 | -117.07% | 5.55 | -55.15% |
| ROE |
|
16.91 | 9.48 | 78.33% |
|
|
| ROA |
|
8.82 | 0.1068 | 8158.63% |
|
|
| ROIC |
|
13.4 | 7.63 | 75.52% |
|
|
| ROS |
|
6.16 | -26.35 | -123.37% |
|
|
| ROCE |
|
0 | 14.58 | -100% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
1/10
|
4.69 | -3.62 | -229.45% | 3.33 | +40.62% |
| Nеt Debt/Ebitda |
|
0 | -4.05 | -100% |
|
|
| Debt/Ratio |
|
0.1674 | 0.1841 | -9.07% |
|
|
| Debt/Equity |
|
0 | 1.6 | -100% |
|
|
| Debt/Net Income |
|
1.89 | 0.9168 | 106.62% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5448 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2387 | -100% |
|
|
| Average dividend growth |
|
0 | 1.55 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4954 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.69 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5448 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-17.47 | 31.71 | -155.09% | ||
| Growth impulse Ebitda in 5 years |
|
51.44 | -23.28 | -320.96% | ||
| Growth impulse Net Income in 5 years |
|
169.51 | -61.56 | -375.36% | ||
| Growth impulse FCF in 5 years |
|
270.67 | -8.35 | -3341.56% | ||
| Growth impulse EPS in 5 years |
|
151 | -64.95 | -332.49% |
IP Score
5.3/10
